Loading Events
  • This event has passed.

Welcome to the presentation at DIA, where Cyntegrity’s CEO Artem Andrianov will be speaking about “The Decisive Role of a Risk-Based Quality System and Risk-Based Monitoring Based on an Example of Two Phase 3 Clinical Trials: A Case Study”

If you plan to visit the DIA annual meeting in 2017 and interested to know more about Risk-based Monitoring (RBM) and the way how it should be implemented in the most scientific genuine way for your company, book an appointment in advance visiting our contact us page. We are looking forward to meeting you in Chicago, IL!